LE WE PMID CA
CNS (Neoplasia Glioblastoma)1009ZNS (Neubildung Glioblastom)

AZD2171

Bevacizumab ttVEGF

Caspase9

Chloroquine

Cilengitide ttRGD

Cimetidine

CNS (Neoplasia Astrocytoma)

CNS (Neoplasia Glioblastoma)

CNS (Neoplasia Glioma)

CNS (Neoplasia Gliosarcoma)

CNS (Neoplasia Oligodendroglioma)

Giant cell glioblastoma

Gliadel wafers

Interleukin24 MDA7

JNK

MTOR

Neoplasia (Tumor biology and immunology)

Neurostatin

PI3K

PTEN MMAC1 TEP1

Radiation therapy

RGD motif

Sec61

SEC61gamma

2010  
1
New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.
[20616955] Onco Targets Ther 3(-): 27-38 (2010)
2006  
2
Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review).
[16596218] Int J Oncol 28(5): 1021-30 (2006)
2010  
3
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
[19817543] J Neurosurg 112(5): 990-6 (2010)
2006  
4
Congenital glioblastoma multiforme. Case report and review of the literature.
[17184081] J Neurosurg 105(6 Suppl): 473-9 (2006)
2006  
5
New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.
[16709037] Neurosurg Focus 20(4): E6 (2006)
2006  
6
Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
[16709039] Neurosurg Focus 20(4): E8 (2006)
2006  
7
Recurrent glioblastoma multiforme: a review of natural history and management options.
[16709036] Neurosurg Focus 20(4): E5 (2006)
2006  
8
Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
[16709035] Neurosurg Focus 20(4): E4 (2006)
2006  
9
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.
[16709028] Neurosurg Focus 20(4): E22 (2006)
2006  
10
Treatment options for glioblastoma.
[16709025] Neurosurg Focus 20(4): E19 (2006)
2006  
11
Gamma knife surgery for glioblastoma multiforme.
[16709022] Neurosurg Focus 20(4): E17 (2006)
2008  
12
Molecular predictors in glioblastoma: toward personalized therapy.
[18625854] Arch Neurol 65(7): 877-83 (2008)
1999  
13
Primary and secondary glioblastomas: from concept to clinical diagnosis.
[11550301] Neuro Oncol 1(1): 44-51 (1999)
2008  
14
PTEN signaling pathways in glioblastoma.
[18836294] Cancer Biol Ther 7(9): 1321-5 (2008)
2009  
15
Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.
[19770591] Cancer Biol Ther 8(19): 1791-7 (2009)
2009  
16
FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme.
[19897538] Oncologist 14(11): 1131-8 (2009)
2009  
17
Chloroquine in glioblastoma--new horizons for an old drug.
[19326448] Cancer 115(11): 2380-3 (2009)
2011  
18
Treatment advances for glioblastoma.
[21955188] Expert Rev Neurother 11(10): 1343-5 (2011)
2008  
19
Drug cocktails for effective treatment of glioblastoma multiforme.
[18416653] Expert Rev Neurother 8(4): 515-7 (2008)
2008  
20
Applications of emerging molecular technologies in glioblastoma multiforme.
[18928343] Expert Rev Neurother 8(10): 1497-506 (2008)
2007  
21
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
[17974913] Genes Dev 21(21): 2683-710 (2007)
2011  
22
Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas.
[21896959] Oncotarget 2(8): 590-8 (2011)
2010  
23
Targeting metabolic remodeling in glioblastoma multiforme.
[21317451] Oncotarget 1(7): 552-62 (2010)
2009  
24
New developments in targeted molecular therapies for glioblastoma.
[19105702] Expert Rev Anticancer Ther 9(1): 7-10 (2009)
2008  
25
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
[18376144] Cancer Biol Ther 7(6): 917-33 (2008)
2009  
26
Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.
[19920201] Cancer Res 69(23): 9105-11 (2009)
2007  
27
Long-term survival with glioblastoma multiforme.
[17785346] Brain 130(Pt 10): 2596-606 (2007)
2010  
28
Recent advances in therapy for glioblastoma.
[20212224] Arch Neurol 67(3): 279-83 (2010)
2007  
29
Gliadel wafers in the treatment of malignant glioma: a systematic review.
[17938702] Curr Oncol 14(5): 189-94 (2007)
2010  
30
Role of bevacizumab therapy in the management of glioblastoma.
[21188100] Cancer Manag Res 2(-): 97-104 (2010)
2008  
31
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.
[18616418] Expert Opin Investig Drugs 17(8): 1225-35 (2008)
2009  
32
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.
[19671039] Expert Opin Investig Drugs 18(10): 1549-57 (2009)
2011  
33
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.
[21214925] Radiat Oncol 6(-): 2 (2011)
2011  
34
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.
[22084619] Clin Med Insights Oncol 5(-): 265-314 (2011)
2011  
35
Bevacizumab for the treatment of recurrent glioblastoma.
[21603247] Clin Med Insights Oncol 5(-): 117-29 (2011)
2008  
36
Giant cell glioblastoma: review of the literature and illustrated case.
[18726045] Neurocirugia (Astur) 19(4): 343-9 (2008)
2011  
37
Long-term survival with primary glioblastoma multiforme: a clinical study in bulgarian patients.
[21537375] Case Rep Oncol 4(1): 1-11 (2011)
2011  
38
Innovative Therapies against Human Glioblastoma Multiforme.
[22091432] ISRN Oncol 2011(-): 787490 (2011)
2011  
39
PI3Kinase signaling in glioblastoma.
[21063898] J Neurooncol 103(3): 417-27 (2011)
2010  
40
mTOR signaling in glioblastoma: lessons learned from bench to bedside.
[20472883] Neuro Oncol 12(8): 882-9 (2010)
2010  
41
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.
[20167819] Neuro Oncol 12(3): 304-16 (2010)
2010  
42
Standard therapy for glioblastoma--a review of where we are.
[20885105] Neurol Med Chir (Tokyo) 50(9): 713-9 (2010)
2011  
43
Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.
[21429292] BMB Rep 44(3): 158-64 (2011)
2008  
44
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
[18352856] Expert Opin Biol Ther 8(4): 541-53 (2008)
2009  
45
STAT3 regulation of glioblastoma pathogenesis.
[19601808] Curr Mol Med 9(5): 580-90 (2009)
2009  
46
Current data and strategy in glioblastoma multiforme.
[20108752] J Med Life 2(4): 386-93 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Hochgradig maligne Gliome und Ponsgliome
  • Gliome


  • Search PubMed and many other databases on the combined search terms

    GG: glioblastoma

  • ZNS (Neubildung Glioblastom)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia